Watch Ticker

Nurix Therapeutics, Inc. Common stock

Go to Nurix Therapeutics, Inc. Common stock Website

$11.28

0.24 (2.17%)

Live

Previous Close

$11.04

Day Range

$10.86 - $11.36

Previous Day Range

$10.86 - $11.32

Market Cap

$844.0 million USD

Day Vol.

439539

Previous Day Vol.

533693

Currency

USD

Primary Exchange

Nasdaq

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disor...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Non-Hodgkin’s Lymphoma Market Forecast to Surge with Growing Adoption of Targeted and Cell-Based Therapies | DelveInsight

The non-Hodgkin's lymphoma market is expected to grow significantly between 2025-2034, driven by increasing incidence, advancements in targeted therapies, emerging treatments, and improved early detection efforts.

Related tickers: SNGX, IPHA, NRIX, MRK.

Read Full Article

Delveinsight - Waldenstrom Macroglobulinemia Market Sees Surging Demand Across the 7MM Amid BTK Inhibitor Advancements | DelveInsight

The Waldenstrom macroglobulinemia market is experiencing steady growth driven by advances in targeted therapies, particularly BTK inhibitors. Rising awareness, improved diagnostics, and increasing clinical trials are propelling market expansion, with several emerging drugs showing promise in treating this rare lymphoma.

Related tickers: CLRB, BGNE, ONC, MRK, NRIX.

Read Full Article

Trending Tickers

Please sign in to view